Patient-reported outcome measures in a population of medically indigent patients with systemic lupus erythematosus in Puerto Rico

被引:2
作者
Rodriguez-Rivera, Diana V. [1 ]
Rodriguez-Navedo, Yerania [1 ]
Nieves-Plaza, Mariely [2 ]
Vila, Luis M. [1 ]
机构
[1] Univ Puerto Rico, Div Rheumatol, Dept Med, Med Sci Campus,POB 365067, San Juan, PR 00936 USA
[2] San Juan Bautista Sch Med, Grad Programs, Caguas, PR USA
来源
SAGE OPEN MEDICINE | 2016年 / 4卷
关键词
Systemic lupus erythematosus; patient-reported outcomes; quality of life; underserved population; Puerto Rico;
D O I
10.1177/2050312116670927
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine patient-reported outcomes measures in indigent patients with systemic lupus erythematosus receiving their healthcare through the Puerto Rico government managed care system and compare these measures with non-indigent patients treated in a private fee-for-service setting. Methods: A cross-sectional study was conducted in a cohort of 98 Puerto Ricans with systemic lupus erythematosus. Patients from the public group (n = 40) were treated in a university-based specialized systemic lupus erythematosus clinic and the private group (n = 58) in a community-based rheumatology practice. Demographic and clinical features and patient-reported outcomes measures per LupusPRO instrument were determined. LupusPRO captures quality-of-life measures in 12 domains. Differences among study groups were examined using chi-square, Fisher's exact, t-tests, and the Wilcoxon signed-rank test. Results: The mean (standard deviation) age of the study population was 44.9 (12.0) years; 94 (95.9%) were women. Patients in the public setting were younger and were more likely to have renal disease and elevated anti-double-stranded DNA antibodies, and being treated with azathioprine and cyclophosphamide. Patients from the public sector were more likely to have better quality-of-life measures in the LupusPRO domains of pain/vitality and coping. No significant differences were observed for the domains of lupus symptoms, physical health, emotional health, body image, cognition, procreation, lupus medications, desires/goals, social support, and satisfaction with medical care. Conclusion: Despite having a lower socioeconomic status and worse clinical status, systemic lupus erythematosus patients from the public sector had equal or better patient-reported outcomes measures than those treated in the private setting. This favorable outcome may be associated with the comprehensive healthcare received by these patients in a specialized lupus clinic.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Patient-Reported Outcomes in Systemic Lupus Erythematosus. Can Lupus Patients Take the Driver's Seat in Their Disease Monitoring?
    Parodis, Ioannis
    Studenic, Paul
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (02)
  • [22] PATIENT-REPORTED OUTCOMES MEASURES FOR SYSTEMIC LUPUS ERYTHEMATOSUS: AN EXPERT DELPHI CONSENSUS TO GUIDE IMPLEMENTATION IN ROUTINE CARE
    Castrejon, I.
    Cano Garcia, L.
    Cuadrado Lozano, M. J.
    Borras, J.
    Galindo-Izquierdo, M.
    Salman Monte, T. C.
    Amoros, C.
    San Roman Gutierrez, C.
    Munoz, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 251 - 251
  • [23] Fighting Fatigue in Systemic Lupus Erythematosus: Experience of Dehydroepiandrosterone on Clinical Parameters and Patient-Reported Outcomes
    Skoglund, Oliver
    Walhelm, Tomas
    Thyberg, Ingrid
    Eriksson, Per
    Sjowall, Christopher
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (18)
  • [24] Categorization of patients with systemic lupus erythematosus using disease activity, patient-reported outcomes, and transcriptomic signatures
    Arcani, Robin
    Jouve, Elisabeth
    Chiche, Laurent
    Jourde-Chiche, Noemie
    CLINICAL RHEUMATOLOGY, 2023, 42 (06) : 1555 - 1563
  • [25] Disease-Specific Patient Reported Outcome Tools for Systemic Lupus Erythematosus
    Jolly, Meenakshi
    Pickard, A. Simon
    Block, Joel A.
    Kumar, Rajan B.
    Mikolaitis, Rachel A.
    Wilke, Caitlyn T.
    Rodby, Roger A.
    Fogg, Louis
    Sequeira, Winston
    Utset, Tammy O.
    Cash, Thomas F.
    Moldovan, Iona
    Katsaros, Emmanuel
    Nicassio, Perry
    Ishimori, Mariko L.
    Kosinsky, Mark
    Merrill, Joan T.
    Weisman, Michael H.
    Wallace, Daniel J.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2012, 42 (01) : 56 - 65
  • [26] Evaluation of a Patient-reported Frailty Tool in Women With Systemic Lupus Erythematosus
    Lieber, Sarah B.
    Nahid, Musarrat
    Paget, Stephen
    Berman, Jessica R.
    Barbhaiya, Medha
    Sammaritano, Lisa R.
    Kirou, Kyriakos
    Carrino, John A.
    Rajan, Mangala
    Sheira, Dina
    Mandl, Lisa A.
    JOURNAL OF RHEUMATOLOGY, 2022, 49 (01) : 60 - 67
  • [27] Assessment of the psychometric properties of patient-reported outcomes of depression and anxiety in systemic lupus erythematosus
    Kwan, Andrew
    Marzouk, Sherief
    Ghanean, Helia
    Kishwar, Ali
    Anderson, Nicole
    Bonilla, Dennisse
    Vitti, Michelle
    Su, Jiandong
    Touma, Zahi
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 49 (02) : 260 - 266
  • [28] Association of Baseline Frailty with Patient-Reported Outcomes in Systemic Lupus Erythematosus at 1 Year
    Lieber, Sarah B.
    Nahid, M.
    Rajan, M.
    Barbhaiya, M.
    Sammaritano, L.
    Lipschultz, R. A.
    Lin, M.
    Reid, M. C.
    Mandl, L. A.
    JOURNAL OF FRAILTY & AGING, 2023, 12 (03) : 247 - 251
  • [29] Validation of the LupusPRO version 1.8: an update to a disease-specific patient-reported outcome tool for systemic lupus erythematosus
    Azizoddin, D. R.
    Weinberg, S.
    Gandhi, N.
    Arora, S.
    Block, J. A.
    Sequeira, W.
    Jolly, M.
    LUPUS, 2018, 27 (05) : 728 - 737
  • [30] Race, ethnicity and patient-reported outcomes in childhood-onset systemic lupus erythematosus
    Borgia, R. E.
    Gurka, M. J.
    Filipp, S. L.
    Elder, M.
    Cardel, M.
    Shiff, N. J.
    CARRA Registry Investigators
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (01) : 186 - 194